Chart review shows nephrologists prescribing more SGLT2 inhibitors

A chart review completed by Spherix Global Insights shows that more nephrologists are using SGLT2 inhibitors to treat patients with chronic kidney disease, according to a press release.
“Analysis of 1,052 chronic kidney disease non-dialysis patient charts reveals continuous growth in SGLT2 inhibitor use and expanding opportunities for [mineralocorticoid receptor agonists] MRAs and [glucagon-like peptide-1] GLP-1s,” according to the release.
In the seventh Patient Chart Dynamix: CKD Non-Dialysis (U.S.) series by Spherix, nephrologists indicated they would use more jardiance

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart